The UBS Asset Management (UBS-AM) Infrastructure Debt Platform has financed CapMan Infra’s acquisition of Koiviston Auto, a Finnish transport operator with the largest bus fleet in the country. The financing will also fund Koiviston Auto’s expansion into electric vehicles, with aims to increase the number of electric buses in its fleet six-fold by 2026 to 33 per cent of total vehicles.   The funding from UBS-AM, acting as the sole lender on the transaction, represents cEUR100 million of debt, allowing CapMan Infra, a Nordic infrastructure investor, to fully acquire Koiviston Auto’s issued share capital. The transaction was the final investment

Private equity firm Willis & Smith Capital and its affiliates have acquired R&B Grinding (R&B), a manufacturer of machined components to a variety of industrial customers, including Fortune 500 original equipment manufacturers. Since its founding in 1958 by the Biddle Family, R&B remains a community pillar employing over 100 team members in its multi-acre manufacturing campus. Willis & Smith Capital’s operating partner, Gene Simon, will serve as Chief Executive Officer. Several key members of the senior management team, including Barb Lange of the Biddle Family, will continue managing R&B’s various operating divisions.

Main Capital Partners (Main) has backed biomedion, a leading GxP data cloud platform provider. biomedion offers an extensive suite of software that is deployed across all “good practice” areas (GxP) in the life and health sciences industry, where quality guidelines and regulations are of paramount importance. biomedion is headquartered in Berlin and has also expanded into the United States with plans to further extend its reach across Europe and North-America.  biomedion represents the third investment from the Main Foundation I fund, which was launched in October 2021 and targets innovative, high-growth software companies.

Ironwood Capital, a provider of non-control growth capital to middle market companies across the US has exited The Facilities Group (TFG), a national facilities maintenance business formed by Revolent Capital Solutions, and a portfolio company of the firm. The Facilities Group is a provider of integrated facilities maintenance solutions. The Company partners with local, regional, and national brands to provide service for customers nationwide across a broad set of end markets.

Industrial Opportunity Partners (IOP), an operations-focused private equity firm, has completed the sale of portfolio company Midwest Paper Group Holdings, Inc (Midwest Paper) to McKinley Paper Company, a subsidiary of Bio Pappel SA de CV (Bio Pappel), a manufacturer of paper and packaging products in North and Latin America. IOP acquired Midwest Paper in December 2019. The divestiture represents IOP’s first investment realisation from its USD450 million third fund, Industrial Opportunity Partners III.  Terms of the transaction have not been disclosed. 

Private investment firm Inverness Graham’s Governance, Risk and Compliance (GRC) solutions company, Syntrio, has acquired ClearView Strategic Partners (ClearView), a provider of ethics reporting & management systems and whistleblower technology solutions. The transaction marks the fifth add-on acquisition completed during Inverness Graham’s ownership, and will provide Syntrio with access to key international geographies as well as an expanded software solutions offering.

Vensica Therapeutics (Vensica), a clinical stage biopharmaceutical company, has closed a USD19 million investment round. Vensica executed a strategic collaboration agreement with Merz Therapeutics in 2021 and the Merz Group is participating in Vensica’s financing with up to USD3 million, bringing the total round to up to USD19 million. The round was led by Israel Biotech Fund (IBF) with the participation of Laborie, Lew Pell, Agriline, and The Trendlines Group.  Merz Therapeutics, a business of the Merz Group, is a specialist in the field of neurotoxins. Vensica has exclusively licensed Merz’s botulinum neurotoxin A (Xeomin®) for needle-free use in urological

Reliance Health, an emerging markets-focused digital healthcare provider, has secured USD40 million in a Series B funding round led by General Atlantic. Partech, Picus Capital, Tencent Exploration, AAIC (Asia Africa Investment and Consulting), P1 Ventures, Laerdal Million Lives Fund, M3, Inc, and Arvantis Social Foundation also participated. With this funding, Reliance Health has successfully closed the largest Series B round in the African HealthTech industry to date. The newly-established partnership also marks General Atlantic’s first technology investment in Africa. To date, Reliance Health has raised USD48 million in total funding, including a USD6 million Series A funding round in January